38 related articles for article (PubMed ID: 38428643)
1. Pancreatobiliary reflux increases macrophage-secreted IL-8 and activates the PI3K/NFκB pathway to promote cholangiocarcinoma progression.
Wu T; Gao R; Wang X; Guo D; Xie Y; Dong B; Hao X; Zhu C
Transl Oncol; 2024 Jul; 45():101967. PubMed ID: 38653100
[TBL] [Abstract][Full Text] [Related]
2. PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma.
Pan YF; Zhong L; Wang M; Jiang TY; Lin YK; Chen YB; Li X; Hu HP; Zhou HB; Yan HZ; Dong LW
Phytomedicine; 2024 May; 131():155790. PubMed ID: 38851099
[TBL] [Abstract][Full Text] [Related]
3. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
Montal R; Sia D; Montironi C; Leow WQ; Esteban-Fabró R; Pinyol R; Torres-Martin M; Bassaganyas L; Moeini A; Peix J; Cabellos L; Maeda M; Villacorta-Martin C; Tabrizian P; Rodriguez-Carunchio L; Castellano G; Sempoux C; Minguez B; Pawlik TM; Labgaa I; Roberts LR; Sole M; Fiel MI; Thung S; Fuster J; Roayaie S; Villanueva A; Schwartz M; Llovet JM
J Hepatol; 2020 Aug; 73(2):315-327. PubMed ID: 32173382
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous activation of Kras-Akt and Notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway.
Namikawa M; Fukuda A; Mizukoshi K; Iwane K; Kawai M; Yamakawa G; Omatsu M; Sono M; Masuda T; Araki O; Nagao M; Yoshikawa T; Ogawa S; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Tsuruyama T; Taura K; Hatano E; Seno H
J Pathol; 2023 Aug; 260(4):478-492. PubMed ID: 37310065
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of bile as a biomarker via ferroptosis and cysteine prenylation in cholangiocarcinoma; role of diagnosis and differentiation from benign biliary disease.
Han JY; Ahn KS; Baek WK; Suh SI; Kim YH; Kim TS; Kang KJ
Surg Oncol; 2020 Sep; 34():174-181. PubMed ID: 32891325
[TBL] [Abstract][Full Text] [Related]
7. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.
Yang Y; Wang J; Wan J; Cheng Q; Cheng Z; Zhou X; Wang O; Shi K; Wang L; Wang B; Zhu X; Chen J; Feng D; Liu Y; Jahan-Mihan Y; Haddock AN; Edenfield BH; Peng G; Hohenstein JD; McCabe CE; O'Brien DR; Wang C; Ilyas SI; Jiang L; Torbenson MS; Wang H; Nakhleh RE; Shi X; Wang Y; Bi Y; Gores GJ; Patel T; Ji B
J Hepatol; 2024 Feb; ():. PubMed ID: 38428643
[TBL] [Abstract][Full Text] [Related]
8. Development of extrahepatic bile ducts and mechanisms of tumorigenesis: Lessons from mouse models.
Tomita H; Hara A
Pathol Int; 2022 Dec; 72(12):589-605. PubMed ID: 36349994
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic.
Cadamuro M; Lasagni A; Lamarca A; Fouassier L; Guido M; Sarcognato S; Gringeri E; Cillo U; Strazzabosco M; Marin JJ; Banales JM; Fabris L
Expert Opin Investig Drugs; 2021 Apr; 30(4):377-388. PubMed ID: 33622120
[No Abstract] [Full Text] [Related]
11. Cell of origin in biliary tract cancers and clinical implications.
Moeini A; Haber PK; Sia D
JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]